Inventor · disambiguated record
Hella Kohlhof
Also filed as: KOHLHOF HELLA
9 granted patents·11 pending applications·10 citations·filing 2014–2024
80Inventor score
Top patents by PatentIndex Score
20 records- 0190US11376232B2Vidofludimus for use in the treatment or prevention of viral diseasesIMMUNIC AG·Filed 2021·Granted Jul 5, 2022·2 cites·29 claims
- 0287US11877994B2Treatment of multiple sclerosis comprising DHODH inhibitorsIMMUNIC AG·Filed 2021·Granted Jan 23, 2024·1 cites·18 claims
- 0382US9951050B2Method of inhibiting DYRK1B4SC DISCOVERY GMBH·Filed 2014·Granted Apr 24, 2018·7 cites·18 claims
- 0481US12433860B2Treatment of multiple sclerosis comprising DHODH inhibitorsIMMUNIC AG·Filed 2023·Granted Oct 7, 2025·0 cites·18 claims
- 0579US2025120931A1Treatment of multiple schlerosis comprising dhodh inhibitorsIMMUNIC AG·Filed 2024·Application pending·0 cites
- 0675US11877995B2Compounds and dosage regimen for use in the prevention or treatment of chronic inflammatory and/or autoimmune diseasesIMMUNIC AG·Filed 2022·Granted Jan 23, 2024·0 cites·34 claims
- 0773US2024100005A1Compounds and Dosage Regimen for Use in the Prevention or Treatment of Chronic Inflammatory and/or Autoimmune DiseasesIMMUNIC AG·Filed 2023·Application pending·0 cites
- 0867US12167994B2Vidofludimus for use in the treatment or prevention of viral diseasesIMMUNIC AG·Filed 2022·Granted Dec 17, 2024·0 cites·19 claims
- 0964US2025136542A1Calcium salt polymorphs as anti-inflammatory, immunodulatory and anti-proliferative agentsIMMUNIC AG·Filed 2024·Application pending·0 cites
- 1063US12037305B2Calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferative agentsIMMUNIC AG·Filed 2019·Granted Jul 16, 2024·0 cites·16 claims
- 1163US2024335405A1Vidofludimus and related structures acting as nurr1 agonistsIMMUNIC AG·Filed 2024·Application pending·0 cites
- 1262US2025243190A1New deuterated rorgamma/rorgammat inverse agonistsIMMUNIC AG·Filed 2023·Application pending·0 cites
- 1360US2025066290A1Dhodh inhibitors containing a carboxylic acid bioisostereIMMUNIC AG·Filed 2022·Application pending·0 cites
- 1460US2025032527A1Medical use of n4-hydroxy citicoline compoundsIMMUNIC AG·Filed 2022·Application pending·0 cites
- 1558US2024368145A1Methods for treating cancerIMMUNIC AG·Filed 2022·Application pending·0 cites
- 1657US10633369B2Method of inhibiting DYRK1B4 SC AG·Filed 2018·Granted Apr 28, 2020·0 cites·14 claims
- 1757US2024199535A1Deuterated dhodh inhibitorsIMMUNIC AG·Filed 2022·Application pending·0 cites
- 1854US2020360324A1Compounds and Dosage Regimen for Use in the Prevention or Treatment of Chronic Inflammatory and/or Autoimmune DiseasesIMMUNIC AG·Filed 2018·Application pending·0 cites
- 1950US2016215348A1Gene expression biomarkers and their use for diagnostic and prognostic application in patients potentially in need of hdac inhibitor treatment4SC AG·Filed 2014·Application pending·0 cites
- 2041US11292788B2IL-17 and IFN-gamma inhibition for the treatment of autoimmune diseases and chronic inflammationIMMUNIC AG·Filed 2018·Granted Apr 5, 2022·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Hella Kohlhof files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →